RecruitingNot ApplicableNCT07060274

Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients


Sponsor

Centre Hospitalier le Mans

Enrollment

64 participants

Start Date

Feb 27, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Giant cell arteritis (GCA) is a rare disease characterized by vasculitis of the large arterial trunks targeting the thoracic aorta and its dividing branches, affecting adults over the age of 50. Vasculitis lesions cause thickening of the arterial wall, visible on temporal artery biopsy (TAB) or vascular imaging (echo-Doppler, angio-CT, angio-MRI, 18FDG PET-CT). This is a severe disease that can lead to blindness. Early diagnosis is essential, so that steroids therapy can be started as soon as possible to prevent complications. Doppler ultrasonography of the temporal arteries provides rapid, non-invasive diagnostic support. However, the recommendations do not specify how soon temporal artery Doppler should be performed after steroids treatment, except that the halo sign would disappear after about 5 days on steroids. Sensitivity seems to be better when the examination is performed early, but the time taken for the halo sign to disappear is unknown. The investigator suggests that the disappearance of the temporal artery halo sign in GCA patients is observed earlier than D14 of steroids treatment usually reported in the literature. He speculates that the sensitivity of the temporal artery Doppler decreases as early as D3 of steroids treatment, and that beyond D7 it is not useful to perform this examination as its sensitivity becomes too low.


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Doppler Ultrasound for people with doppler ultrasound and giant cell arteritis (gca). The study is currently recruiting participants at 6 locations. People eligible for this study include aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDoppler Ultrasound

Doppler ultrasound of temporal arteries at D0, D3 and D7 (+ D15 if halo detected at D7) after initiation of corticosteroid therapy.


Locations(6)

Centre Hospitalier du Mans

Le Mans, Sarthe, France

CHU d'Angers

Angers, France

CHU Caen Normandie

Caen, France

CHU Dijon - Hôpital François Mitterrand

Dijon, France

Groupe hospitalier La Rochelle-Ré-Aunis

La Rochelle, France

CHU Nantes

Nantes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07060274


Related Trials